Ethyl 2-(4-(hydroxymethyl)piperidin-1-yl)pyrimidine-5-carboxylate, 95.0%, 25g

2-(4-Fluorophenyl)-5-methylpyridine, 97%, 250mg

6-chloro-N~4~,N~4~-dimethyl-2,4-pyrimidinediamine, 95.0%, 5g

Methyl 3-Methoxyphenylacetate>98.0%(GC)25g

1-(4-Chloro-6-fluorobenzo[d]thiazol-2-yl)azetidin-3-ol, 5g

3-Aminophenylboronic acid monohydrate, 97.0%, 100g

2-chloro-N-(3-chloro-2-fluorophenyl)acetamide, 1g

1-(5-Fluoro-2-methyl-3-nitrophenyl)ethanone, 98+%, 10g

methyl 3-[(3-aminocyclobutanecarbonyl)amino]cyclobutanecarboxylate hydrochloride, 97.0%, 500mg

4-((2-Aminoethyl)amino)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione hydrochloride, 98%, 5mg

2-Methylsulfanyl-nicotinic acid, 95.0%, 5g

N,N'-Bis(acryloyl)cystamine>95.0%(HPLC)1g

Buffer solution pH 4.62 ±0.02 (20 °C), ROTI®Calipure ready to use, 1 l, plastic packaging.